JOHN FARMER to Male
This is a "connection" page, showing publications JOHN FARMER has written about Male.
Connection Strength
0.096
-
Strategies for multivessel revascularization in patients with diabetes: the FREEDOM trial. Curr Atheroscler Rep. 2014 Jul; 16(7):426.
Score: 0.015
-
The effect of statins on skeletal muscle function: the STOMP trial. Curr Atheroscler Rep. 2013 Aug; 15(8):347.
Score: 0.014
-
High-density lipoprotein and atherosclerosis: the role of antioxidant activity. Curr Atheroscler Rep. 2012 Apr; 14(2):101-7.
Score: 0.013
-
Evolving concepts of the role of high-density lipoprotein in protection from atherosclerosis. Curr Atheroscler Rep. 2011 Apr; 13(2):107-14.
Score: 0.012
-
Platelet inhibition with tirofiban early during percutaneous coronary intervention: dosing revisited. Catheter Cardiovasc Interv. 2002 Aug; 56(4):474-7.
Score: 0.007
-
The renin angiotensin system as a risk factor for coronary artery disease. Curr Atheroscler Rep. 2001 Mar; 3(2):117-24.
Score: 0.006
-
Coronary heart disease: clinical trials review. Curr Atheroscler Rep. 2000 May; 2(3):189-93.
Score: 0.006
-
Association between preoperative diuretic use and in-hospital outcomes after cardiac surgery. Cardiovasc Ther. 2013 Oct; 31(5):291-7.
Score: 0.004
-
Comparative effects of simvastatin and lovastatin in patients with hypercholesterolemia. The Simvastatin and Lovastatin Multicenter Study Participants. Clin Ther. 1992 Sep-Oct; 14(5):708-17.
Score: 0.003
-
Simvastatin decreases myocardial tumor necrosis factor alpha content in heart transplant recipients. J Heart Lung Transplant. 2005 Jan; 24(1):46-51.
Score: 0.002
-
The implications for cardiac recovery of left ventricular assist device support on myocardial collagen content. Am J Surg. 2000 Dec; 180(6):498-501; discussion 501-2.
Score: 0.001
-
Tirofiban for cocaine-induced coronary artery thrombosis: a novel therapeutic approach. Circulation. 1999 Nov 02; 100(18):1939.
Score: 0.001
-
Influence of low HDL on progression of coronary artery disease and response to fluvastatin therapy. Circulation. 1999 Feb 16; 99(6):736-43.
Score: 0.001
-
Intensive medical therapy versus coronary angioplasty for suppression of myocardial ischemia in survivors of acute myocardial infarction: a prospective, randomized pilot study. Circulation. 1998 Nov 10; 98(19):2017-23.
Score: 0.001
-
Progressive deterioration of coronary flow reserve after heart transplantation. Am Heart J. 1998 Sep; 136(3):504-9.
Score: 0.001
-
Images in cardiovascular medicine. Fistula between left main, left anterior descending, and pulmonary arteries. Circulation. 1998 May 26; 97(20):2091-2.
Score: 0.001
-
Effects of lipid lowering therapy on progression of coronary and carotid artery disease. Curr Opin Lipidol. 1997 Dec; 8(6):354-61.
Score: 0.001
-
Effects of fluvastatin on coronary atherosclerosis in patients with mild to moderate cholesterol elevations (Lipoprotein and Coronary Atherosclerosis Study [LCAS]). Am J Cardiol. 1997 Aug 01; 80(3):278-86.
Score: 0.001
-
Association of angiotensin I-converting enzyme gene polymorphism with myocardial ischemia and patency of infarct-related artery in patients with acute myocardial infarction. J Am Coll Cardiol. 1997 Jun; 29(7):1468-73.
Score: 0.001
-
Effect of gemfibrozil on levels of lipoprotein[a] in type II hyperlipoproteinemic subjects. J Lipid Res. 1996 Jun; 37(6):1298-308.
Score: 0.001
-
Baseline characteristics of subjects in the Lipoprotein and Coronary Atherosclerosis Study (LCAS) with fluvastatin. Am J Cardiol. 1994 May 26; 73(14):42D-49D.
Score: 0.001
-
Once-daily pravastatin in patients with primary hypercholesterolemia: a dose-response study. Clin Cardiol. 1991 Feb; 14(2):146-51.
Score: 0.001